via Kagan Institute
Breakthrough by experts supports drug therapy as alternative to surgery
World-leading eye experts have made a breakthrough that could potentially change the way cataracts are treated – with potential for drug therapy to replace surgery.
Cataract is a clouding of the eye lens that develops over time and affects the quality of vision. It is caused by an accumulation of protein in the lens that reduce the transmission of light to the retina. Previous research led by ARU found that cataracts account for almost half of global cases of blindness.
A significantly developed cataract can only currently be treated by a surgical procedure to remove the cloudy lens and insert an artificial replacement.
A team of international scientists, led by Professor Barbara Pierscionek of Anglia Ruskin University (ARU), has published peer-reviewed research that shows the sophisticated optics of the lens develops much earlier in gestation than has previously been thought possible. They also found how a particular protein (aquaporin) responsible for water passage in the lens disrupts the optical development, leading to cataract formation.
The scientists have spent more than a decade conducting the most precise measurements on optics of the lens at SPring-8, the world’s largest and most powerful synchrotron, in Japan.
The synchrotron is a particle accelerator that produces powerful X-rays by accelerating electrons to the speed of light. The X-rays allow measurements to be taken with the highest accuracy yet on optical properties of the eye.
The project team is the first in the world to have measured how the optics in the eye lens develop. Their research was presented earlier this month at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting.
Professor Pierscionek, Deputy Dean (Research and Innovation) for the Faculty of Health, Education, Medicine and Social Care and member of the Medical Technology Research Centre at ARU, said: “Cataracts are one of the main causes of vision loss and blindness worldwide, yet for many people surgery is inaccessible for various reasons.
“Our findings indicate the role of the aquaporin proteins and the crucial importance of this for the lens to work correctly and the eye to see clearly.
“Further research in this area is planned, but this discovery, together with our research on nanotechnologies that indicate drug therapy for cataract is possible, could potentially revolutionise the way cataract is treated, opening up the field for drug-based therapy rather than surgery. This would have exciting implications for public health.”
Original Article: New research may revolutionise cataract treatment
More from: Anglia Ruskin University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cataracts
- State buys former Maui Sun Hotel for $38M
The state bought the former hotel from the Haggai International Institute for Advanced Leadership Training for $38 million. The newly-renamed Hale O Laie has 175 guest rooms. Survivors are expected to ...
- Eye Protection during summer
Thus, with adequate safety precautions, it is possible to protect your eyes and enjoy your summer to the fullest. Prevent sun damage beforehand by following these above steps. If you continue to face ...
- Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
Govorestat is a central nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) in development for the treatment of several rare neurological diseases, including Galactosemia, SORD Deficiency, ...
- Harvard Health Publishing And 3 More Doctors Weigh In On: When Should You Get Your Cataracts Removed?
Answered by Dr. Howard E. Lewine M.D. Chief Medical Editor, Harvard Health Publishing · 40 years of experience · USA Typically, the vision changes associated with cataracts slowly worsen over time.
- Preparing for an allergic reaction
Allergic reactions can range from irritating sneezing fits to life-threatening episodes. An allergy specialist with Baylor College of Medicine gives ...
Go deeper with Google Headlines on:
Cataracts
[google_news title=”” keyword=”cataracts” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Drug therapy for cataracts
- Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
Govorestat is a central nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) in development for the treatment of several rare neurological diseases, including Galactosemia, SORD Deficiency, ...
- Aurion Biotech doses first Canadian patient in Phase 1/2 ABA-1, CLARA clinical trial of AURN001
The 1-time, intracameral injection is a cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction.
- Preparing for an allergic reaction
Allergic reactions can range from irritating sneezing fits to life-threatening episodes. An allergy specialist with Baylor College of Medicine gives ...
- Navigating ocular effects of cancer therapy: Insights from breast cancer and head-neck cancers
The symptoms related to targeted cancer therapy (TCT) and immunotherapy for head and neck cancers include photosensitivity, loss of eyelashes, uveitis, changes in color perception, conjunctivitis, ...
- Here's What to Look for During an Eclipse-Related Eye Visit
Sun-related injuries, of course, are the first thing to look for in the wake of the April 8 eclipse, which will be visible over much of the U.S. and Canada. A small strip of the U.S., from near San ...
Go deeper with Google Headlines on:
Drug therapy for cataracts
[google_news title=”” keyword=”drug therapy for cataracts” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]